Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for EW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 13.87%
March 31, 2026 23.09%
December 31, 2025 4.09%
September 30, 2025 18.82%
June 30, 2025 21.92%
March 31, 2025 25.74%
December 31, 2024 24.90%
September 30, 2024 26.74%
June 30, 2024 26.58%
March 31, 2024 24.43%
December 31, 2023 26.30%
September 30, 2023 26.93%
June 30, 2023 19.62%
March 31, 2023 23.33%
December 31, 2022 29.55%
September 30, 2022 26.04%
June 30, 2022 29.58%
March 31, 2022 27.86%
December 31, 2021 25.22%
September 30, 2021 25.96%
June 30, 2021 35.57%
March 31, 2021 27.80%
December 31, 2020 25.97%
September 30, 2020 28.50%
June 30, 2020 -13.18%
Date Value
March 31, 2020 27.52%
December 31, 2019 23.87%
September 30, 2019 25.11%
June 30, 2019 22.29%
March 31, 2019 25.15%
December 31, 2018 0.72%
September 30, 2018 24.92%
June 30, 2018 29.96%
March 31, 2018 23.09%
December 31, 2017 -0.32%
September 30, 2017 20.71%
June 30, 2017 22.11%
March 31, 2017 26.06%
December 31, 2016 20.65%
September 30, 2016 19.12%
June 30, 2016 16.67%
March 31, 2016 20.51%
December 31, 2015 20.97%
September 30, 2015 19.19%
June 30, 2015 18.27%
March 31, 2015 20.90%
December 31, 2014 17.67%
September 30, 2014 15.57%
June 30, 2014 95.11%
March 31, 2014 11.54%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Stryker Corp. 19.37%
Intuitive Surgical, Inc. 28.46%
Abbott Laboratories 7.37%
Boston Scientific Corp. 16.63%
Zimmer Biomet Holdings, Inc. 9.17%